|1.||Barnett, Brad P: 2 articles (02/2011 - 04/2009)|
|2.||Gailloud, Philippe: 1 article (02/2011)|
|3.||Hughes, Andrew H: 1 article (04/2009)|
|4.||Lin, Sopo: 1 article (04/2009)|
|5.||Gailloud, Philippe H: 1 article (04/2009)|
|6.||Arepally, Aravind: 1 article (04/2009)|
02/01/2011 - "The embolic and contrast properties of EmboGel were assessed in in vitro models of saccular aneurysm and an aortic aneurysm endoleak. "
04/01/2009 - "To describe two hydrogel embolic materials, the alginate-based EmboGel and the polyethylene glycol diacrylate-based UltraGel and examine their use as embolic agents in in vitro models of abdominal aortic aneurysm (AAA) endoleak and saccular aneurysms. "
02/01/2011 - "The dissolvability of EmboGel with EmboClear was assessed further after endovascular delivery in the New Zealand white rabbit in the native aortoiliofemoral territory, a created saccular aneurysm, and the native carotid arteries. "
04/01/2009 - "Preliminary in vitro results suggest that EmboGel and UltraGel provide effective embolization in fusiform and saccular aneurysm models, respectively. "
02/01/2011 - "EmboGel effectively filled aneurysm cavities in the case of stent excluded saccular and fusiform aneurysms. "
02/01/2011 - "To evaluate the embolic properties of an alginate-based embolic biomaterial (EmboGel) and its solvent (EmboClear) in treatment of aneurysms. "
04/01/2009 - "In vitro assessment of EmboGel and UltraGel radiopaque hydrogels for the endovascular treatment of aneurysms."
|3.||Abdominal Aortic Aneurysm
|4.||Aortic Aneurysm (Aneurysm, Aortic)
|1.||alginic acid (sodium alginate)
|4.||Polyethylene Glycols (Polyethylene Glycol)